Background Although zidovudine prophylaxis decreases the rate of transmission of the
human immunodeficiency virus (HIV) type 1 substantially, a large number of infants still …

Background In 1999, we reported safety and efficacy data for short-course nevirapine from a
Ugandan perinatal HIV-1 prevention trial when 496 babies were followed up to age 14–16 …

ContextAntenatal counseling and human immunodeficiency virus (HIV) testing are not
universal in Africa; thus, women often present in labor with unknown HIV status without …

Background: Single-dose nevirapine given to women and infants reduces mother-to-child
HIV transmission, but nevirapine resistance develops in a large percentage of women …

The aim of this study was to investigate the implementation of a prevention of mother-to-child
transmission (PMTCT) program and to evaluate the uptake and adherence to single-dose …

Background: Large numbers of women receive single-dose nevirapine (sdNVP) to prevent
mother-to-child transmission (MTCT) of HIV; over time, an increasing proportion will return to …

Objectives: To describe experiences, and identify factors associated with nonadherence to a
single-dose nevirapine (SD-NVP) regimen for the prevention of mother-to-child transmission …

Objective: To compare the rate of mother-to-child transmission (MTCT) in women with
subtype A versus D HIV-1 who received single-dose nevirapine (NVP). Methods: The MTCT …

Universal nevirapine (NVP) therapy (provision of the drug without HIV testing) has been
suggested as potentially superior to targeted NVP therapy (provision of the drug to …

Objectives To determine factors associated with pregnant women being HIV positive,
barriers to the uptake of single‐dose nevirapine (sdNVP) for prevention of mother‐to‐child …